115 related articles for article (PubMed ID: 21923778)
1. EUCAST technical note on anidulafungin.
Arendrup MC; Rodriguez-Tudela JL; Lass-Flörl C; Cuenca-Estrella M; Donnelly JP; Hope W;
Clin Microbiol Infect; 2011 Nov; 17(11):E18-20. PubMed ID: 21923778
[TBL] [Abstract][Full Text] [Related]
2. EUCAST technical note on posaconazole.
Arendrup MC; Cuenca-Estrella M; Donnelly JP; Hope W; Lass-Flörl C; Rodriguez-Tudela JL;
Clin Microbiol Infect; 2011 Nov; 17(11):E16-7. PubMed ID: 21923779
[TBL] [Abstract][Full Text] [Related]
3. EUCAST technical note on Amphotericin B.
Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
[TBL] [Abstract][Full Text] [Related]
4. EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
Mycoses; 2014 Jun; 57(6):377-9. PubMed ID: 24417759
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
7. EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW;
Clin Microbiol Infect; 2012 Jul; 18(7):E248-50. PubMed ID: 22540149
[TBL] [Abstract][Full Text] [Related]
8. EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.
Arendrup MC; Jørgensen KM; Hare RK; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285230
[TBL] [Abstract][Full Text] [Related]
9. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
11. EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.
Arendrup MC; Meletiadis J; Mouton JW; Guinea J; Cuenca-Estrella M; Lagrou K; Howard SJ;
Clin Microbiol Infect; 2016 Jun; 22(6):571.e1-4. PubMed ID: 26851656
[TBL] [Abstract][Full Text] [Related]
12. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
[TBL] [Abstract][Full Text] [Related]
13. EUCAST breakpoints for antifungals.
Rodríguez-Tudela JL; Arendrup MC; Cuenca-Estrella M; Donnelly JP; Lass-Flörl C
Drug News Perspect; 2010 Mar; 23(2):93-7. PubMed ID: 20369073
[TBL] [Abstract][Full Text] [Related]
14. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K;
Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
[TBL] [Abstract][Full Text] [Related]
15. EUCAST technical note on voriconazole and Aspergillus spp.
Hope WW; Cuenca-Estrella M; Lass-Flörl C; Arendrup MC;
Clin Microbiol Infect; 2013 Jun; 19(6):E278-80. PubMed ID: 23413937
[TBL] [Abstract][Full Text] [Related]
16. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope W;
Clin Microbiol Infect; 2012 Jul; 18(7):E246-7. PubMed ID: 22563750
[TBL] [Abstract][Full Text] [Related]
17. Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.
Ghannoum MA; Chen A; Buhari M; Chandra J; Mukherjee PK; Baxa D; Golembieski A; Vazquez JA
Clin Microbiol Infect; 2009 Mar; 15(3):274-9. PubMed ID: 19210699
[TBL] [Abstract][Full Text] [Related]
18. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
20.
Meletiadis J; Curfs-Breuker I; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
